Lung cancer is the leading cause of cancer deaths worldwide, mainly because it gets detected late. The discovery by the ...
8 小时
The Everymom on MSNDon’t Skip Your Screenings: A Doctor Shares What to Know About Pre-CancerApproximately 40.5 percent of Americans will be diagnosed with cancer at some point in their life. It’s a diagnosis no ...
The European Commission approves AstraZeneca's Imfinzi for treating patients with limited-stage small-cell lung cancer based ...
BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...
A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some ...
AstraZeneca's eneboparatide met its Phase 3 trial goal for chronic hypoparathyroidism, while the EU approved Imfinzi for ...
Economic Toxicity, Lung Cancer, Multi-Center Trial, Correlation Analysis Share and Cite: Mao, R.M. and Peng, L.Y. (2025) Multi-Center Investigation on the Level of Economic Toxicity in Patients with ...
Chen, F. (2025) Advances in the Application of Deep Learning in Prognostic Models for Non-Small Cell Lung Cancer. Health, 17, ...
The following is a summary of "Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma ...
Approval based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo ...
A study reveals how cancer disrupts RNA splicing and presents a potential therapy using antisense oligonucleotides to target ...
The safety profile for Imfinzi was generally manageable and consistent with the known profile of this medicine.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果